|
|
TTD Drug ID:
DNC004082
Drug
Information |
Name | 5-[(1R)-1-ammonioethyl]isoxazol-3-olate | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C5H8N2O2/c1-3(6)4-2-5(8)7-9-4/h2-3H,6H2,1H3,(H,7,8)/t3-/m1/s1 | InChIKey | ICRYUJPBYIPXQF-GSVOUGTGSA-N | Canonical SMILES | CC(C1=CC(=O)NO1)N | Isomeric SMILES | C[C@H](C1=CC(=O)NO1)N | Target | GABA receptor alpha-1 subunit |  | Inhibitor | [1] | GABA receptor alpha-2 subunit |  | Inhibitor | [1] | GABA receptor alpha-3 subunit |  | Inhibitor | [1] | GABA receptor alpha-5 subunit |  | Inhibitor | [1] | GABA receptor beta-2 subunit |  | Inhibitor | [1] | GABA receptor gamma-2 subunit |  | Inhibitor | [1] | GABA receptor pi subunit |  | Inhibitor | [1] | Ref 1 | J Med Chem. 1981 Dec;24(12):1377-83.gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|